A group of researchers from the University of Erlangen-Nuremberg has discovered which immune cells migrate from the skin of ...

Discover why psoriasis treatments may lose effectiveness and explore alternatives. Learn about the potential of biologics, ...

Psoriasis can increase skin infection risk due to effects from the condition and its treatments. Learn about potential infections, symptoms, and preventive measures.

Alumis Inc. surged on Phase 3 psoriasis data for envudeucitinib. Click for this look at ALMS stock and why I am bullish on ...

Arrowhead Pharmaceuticals disclosed that its gene-silencing candidates helped people with obesity lose fat, very early ...

Alumis said on Tuesday its experimental drug met the main goal of improving symptoms of a common skin disease in two late-stage studies, powering its shares to a record high and more than doubling ...

Scalp flaking seems harmless and picking the scabs can even be satisfying for many. However, it may signal more serious ...

Takeda’s zasocitinib has shown strong rates of skin clearance, as well as other benefits, in new study results regarding ...

Eli Lilly said on Thursday a late-stage trial showed its weight-loss drug Zepbound, used with its psoriatic arthritis ...

BRITS have been urged to be vigilant after a surge in cases of a highly infectious Victorian disease that can trigger ...

Both Phase 3 trials met all primary and secondary endpoints with high statistical significance in patients with moderate-to-severe plaque ...

Experts review warning nail features, from inflammatory conditions to tumours, offering practical guidance on diagnosis and ...